Business Context and Reporting Period
Company: Bioaffinity Technologies, Inc. (BIAF)
Filing Type: Form 8-K (Current Report)
Date of Report: March 26, 2026
Reporting Period: Single event date (March 26, 2026)
Business Context: The Company is a Delaware corporation listed on the Nasdaq Capital Market. This filing serves as a Regulation FD disclosure to make public presentation materials regarding the Company's operations and performance.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing to disclose the existence of presentation materials rather than a financial statement.
Material Changes
No material financial changes or operational updates are detailed within the text of this 8-K. The sole material event is the public release of "Presentation Materials" (Exhibit 99.1) intended for use in management presentations.
Guidance, Outlook, and Risks
- Management Commentary: Management intends to use the attached presentation materials from time to time to discuss operations and performance.
- Legal Disclaimer: The information in Item 7.01 and Exhibit 99.1 is furnished, not "filed," under the Exchange Act. It is not subject to Section 18 liabilities and shall not be incorporated by reference into other filings.
- Emerging Growth Company Status: The registrant is identified as an emerging growth company.
Investor Verification Checklist
- Review Exhibit 99.1 (Presentation Materials – March 2026) for actual operational data and financial projections, as the 8-K text only references these materials.
- Verify the trading status of Common Stock (BIAF) and Warrants (BIAFW) on the Nasdaq Capital Market.
- Confirm the Company's Emerging Growth Company status implications for future financial reporting standards.